The global population is aging rapidly, posing unprecedented challenges to health care systems. This study investigates the often-overlooked role of macrophages in microvascular dysfunction associated with aging. We use a three-dimensional in vitro hydrogel model to assess the effects of both age and metformin, an anti-aging therapeutic, on macrophage interactions with microvasculature. Metformin's broad cellular impact is a subject of significant interest, yet its precise mechanisms remain unclear. Our research reveals that metformin treatment enhances genetic pathways associated with macrophage-mediated support of angiogenesis, resulting in increased microvessel density. Of importance, monocyte chemoattractant protein-1 expression is upregulated with metformin treatment and positively correlated with microvascular volume, shedding light on a potential mechanism for metformin's promotion of macrophage support of vasculogenesis. This work not only uncovers metformin's impact on human macrophages but also supports its potential as an antiaging therapeutic, offering new avenues for combating age-related diseases.
Impact statement
Our work will contribute to the ongoing discourse on aging biology and the potential applications of metformin in addressing age-related health challenges. The implications of our findings have the potential to inform the development of targeted therapeutic interventions for age-related diseases and contribute to our understanding of metformin's anti-aging properties.
Get full access to this article
View all access options for this article.
References
1.
United Nations, Department of Economics and Social Affairs. World Population Ageing, 2019: Highlights. New York: United Nations; 2019..
2.
DallTM, GalloPD, ChakrabartiR, et al.An aging population and growing disease burden will require a large and specialized health care workforce by 2025. Health Aff (Millwood), 2013; 32(11):2013–2020; doi: 10.1377/hlthaff.2013.0714
3.
YazdanyarA, NewmanAB. The burden of cardiovascular disease in the elderly: Morbidity, mortality, and costs. Clin Geriatr Med, 2009; 25(4):563–577; doi: 10.1016/j.cger.2009.07.007
4.
SleemanKE, de BritoM, EtkindS, et al.The escalating global burden of serious health-related suffering: Projections to 2060 by world regions, age groups, and health conditions. Lancet Glob Health, 2019; 7(7):e883–e892; doi: 10.1016/S2214-109X(19)30172-X
5.
MouraJ, MadureiraP, LealEC, et al.Immune aging in diabetes and its implications in wound healing. Clin Immunol, 2019; 200:43–54; doi: 10.1016/j.clim.2019.02.002
6.
OlivieriF, PrattichizzoF, GrillariJ, et al.Cellular senescence and inflammaging in age-related diseases. Mediators Inflamm, 2018; 2018:e9076485; doi: 10.1155/2018/9076485
7.
FerrucciL, Gonzalez-FreireM, FabbriE, et al.Measuring biological aging in humans: A quest. Aging Cell, 2020; 19(2):e13080; doi: 10.1111/acel.13080
8.
KlineKA, BowdishDM. Infection in an aging population. Curr Opin Microbiol, 2016; 29:63–67; doi: 10.1016/j.mib.2015.11.003
9.
BentovI, ReedMJ. The effect of aging on the cutaneous microvasculature. Microvasc Res, 2015; 100:25–31; doi: 10.1016/j.mvr.2015.04.004
10.
JinK. A microcirculatory theory of aging. Aging Dis, 2019; 10(3):676–683; doi: 10.14336/AD.2019.0315
11.
Krüger-GengeA, BlockiA, FrankeRP, et al.Vascular endothelial cell biology: An update. Int J Mol Sci, 2019; 20(18); doi: 10.3390/ijms20184411
12.
DonatoAJ, MachinDR, LesniewskiLA. Mechanisms of dysfunction in the aging vasculature and role in age-related disease. Circ Res, 2018; 123(7):825–848; doi: 10.1161/CIRCRESAHA.118.312563
13.
DeFalcoT, BhattacharyaI, WilliamsAV, et al.Yolk-sac-derived macrophages regulate fetal testis vascularization and morphogenesis. Proc Natl Acad Sci U S A, 2014; 111(23):E2384–E2393; doi: 10.1073/pnas.1400057111
14.
FantinA, VieiraJM, GestriG, et al.Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. Blood, 2010; 116(5):829–840; doi: 10.1182/blood-2009-12-257832
15.
HernandezGE, Iruela-ArispeML. The many flavors of monocyte/macrophage-–endothelial cell interactions. Curr Opin Hematol, 2020; 27(3):181–189; doi: 10.1097/MOH.0000000000000573
16.
KaluckaJ, BierhanslL, WielockxB, et al.Interaction of endothelial cells with macrophages–linking molecular and metabolic signaling. Pflugers Arch, 2017; 469(3–4):473–483; doi: 10.1007/s00424-017-1946-6
17.
HeH, XuJ, WarrenCM, et al.Endothelial cells provide an instructive niche for the differentiation and functional polarization of M2-like macrophages. Blood, 2012; 120(15):3152–3162; doi: 10.1182/blood-2012-04-422758
18.
AlbrightJM, DunnRC, ShultsJA, et al.Advanced age alters monocyte and macrophage responses. Antioxid Redox Signal, 2016; 25(15):805–815; doi: 10.1089/ars.2016.6691
19.
De MaeyerRPH, ChambersES. The impact of ageing on monocytes and macrophages. Immunol Lett, 2021; 230:1–10; doi: 10.1016/j.imlet.2020.12.003
20.
LloberasJ, CeladaA. Effect of aging on macrophage function. Exp Gerontol, 2002; 37(12):1325–1331; doi: 10.1016/S0531-5565(02)00125-0
21.
FranceschiC, BonafeáM, ValensinS. Human immunosenescence: The prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine, 2000; 18(16):1717–1720.
22.
SilbermanJ, BoehleinJ, AbbateT, et al.A biomaterial model to assess the effects of age in vascularization. Cells Tissues Organs, 2023; 212(1):74–83; doi: 10.1159/000523859
23.
Schmauck-MedinaT, MolièreA, LautrupS, et al.New hallmarks of ageing: A 2022 Copenhagen ageing meeting summary. Aging, 2022; 14(16):6829–6839; doi: 10.18632/aging.204248
24.
BarzilaiN, CrandallJP, KritchevskySB, et al.Metformin as a tool to target aging. Cell Metab, 2016; 23(6):1060–1065; doi: 10.1016/j.cmet.2016.05.011
25.
KonopkaAR, MillerBF. Taming expectations of metformin as a treatment to extend healthspan. GeroScience, 2019; 41(2):101–108; doi: 10.1007/s11357-019-00057-3
26.
AnisimovVN, EgorminPA, PiskunovaTS, et al.Metformin extends life span of HER-2/neu transgenic mice and in combination with melatonin inhibits growth of transplantable tumors in vivo. Cell Cycle, 2010; 9(1):188–197; doi: 10.4161/cc.9.1.10407
27.
KulkarniAS, GubbiS, BarzilaiN. Benefits of metformin in attenuating the hallmarks of aging. Cell Metab, 2020; 32(1):15–30; doi: 10.1016/j.cmet.2020.04.001
28.
HundalRS, KrssakM, DufourS, et al.Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes, 2000; 49(12):2063–2069; doi: 10.2337/diabetes.49.12.2063
29.
ForetzM, GuigasB, ViolletB. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nat Rev Endocrinol, 2019; 15(10):569–589; doi: 10.1038/s41574-019-0242-2
30.
CabreiroF, AuC, LeungK-Y, et al.Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell, 2013; 153(1):228–239; doi: 10.1016/j.cell.2013.02.035
MohammedI, HollenbergMD, DingH, et al.A critical review of the evidence that metformin is a putative anti-aging drug that enhances healthspan and extends lifespan. Front Endocrinol (Lausanne), 2021; 12:18942.
33.
RomeroR, ErezO, HüttemannM, et al.Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. Am J Obstet Gynecol, 2017; 217(3):282–302; doi: 10.1016/j.ajog.2017.06.003
34.
WangX, LiuY, HanD, et al.Dose-dependent immunomodulatory effects of metformin on human neonatal monocyte-derived macrophages. Cell Immunol, 2022; 377:104557; doi: 10.1016/j.cellimm.2022.104557
35.
IsodaK, YoungJL, ZirlikA, et al.Metformin inhibits proinflammatory responses and nuclear factor-κB in human vascular wall cells. Arterioscler Thromb Vasc Biol, 2006; 26(3):611–617; doi: 10.1161/01.ATV.0000201938.78044.75
36.
HolzscheckN, SöhleJ, KristofB, et al.Multi-omics network analysis reveals distinct stages in the human aging progression in epidermal tissue. Aging, 2020; 12(12):12393–12409; doi: 10.18632/aging.103499
37.
MooreEM, YingG, WestJL. Macrophages influence vessel formation in 3D bioactive hydrogels. Adv Biosyst, 2017; 1(3):1600021; doi: 10.1002/adbi.201600021
38.
YangY, KimSC, YuT, et al.Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses. Mediators Inflamm, 2014; 2014:e352371; doi: 10.1155/2014/352371.
39.
JebaliA, DumazN. The role of RICTOR downstream of receptor tyrosine kinase in cancers. Mol Cancer, 2018; 17(1):39; doi: 10.1186/s12943-018-0794-0
40.
LiangX, SunR, ZhaoX, et al.Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway. J Cell Mol Med, 2017; 21(12):3579–3591; doi: 10.1111/jcmm.13268
41.
GriebG, MerkM, BernhagenJ, et al.Macrophage migration inhibitory factor (MIF): A promising biomarker. Drug News Perspect, 2010; 23(4):257–264; doi: 10.1358/dnp.2010.23.4.1453629
42.
YadatiT, HoubenT, BitorinaA, et al.The ins and outs of cathepsins: Physiological function and role in disease management. Cells, 2020; 9(7):1679; doi: 10.3390/cells9071679
43.
SchutyserE, StruyfS, Van DammeJ. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev, 2003; 14(5):409–426; doi: 10.1016/S1359-6101(03)00049-2
44.
ArltA, SchäferH. Role of the immediate early response 3 (IER3) gene in cellular stress response, inflammation and tumorigenesis. Eur J Cell Biol, 2011; 90(6):545–552; doi: 10.1016/j.ejcb.2010.10.002
45.
ShiT-T, LiG, XiaoH-T. The role of RhoJ in endothelial cell biology and tumor pathology. BioMed Res Int, 2016; 2016:e6386412; doi: 10.1155/2016/6386412
CribbsDH, BerchtoldNC, PerreauV, et al.Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: A microarray study. J Neuroinflammation, 2012; 9(1):179; doi: 10.1186/1742-2094-9-179
48.
MooreEM, SureshV, YingG, et al.M0 and M2 macrophages enhance vascularization of tissue engineering scaffolds. Regen Eng Transl Med, 2018; 4(2); doi: 10.1007/s40883-018-0048-0
49.
BrewerWJ, Xet-MullAM, YuA, et al.Macrophage NFATC2 mediates angiogenic signaling during mycobacterial infection. Cell Rep, 2022; 41(11):111817; doi: 10.1016/j.celrep.2022.111817
50.
BattleA, KhanZ, WangSH, et al.Impact of regulatory variation from RNA to protein. Science, 2015; 347(6222):664–667; doi: 10.1126/science.1260793
51.
HanJ, LiY, LiuX, et al.Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo. PLoS One, 2018; 13(3):e0193031; doi: 10.1371/journal.pone.0193031
52.
HattoriY, SuzukiK, HattoriS, et al.Metformin inhibits cytokine-induced nuclear factor κB activation via AMP-activated protein kinase activation in vascular endothelial cells. Hypertension, 2006; 47(6):1183–1188; doi: 10.1161/01.HYP.0000221429.94591.72
53.
ZhangY, LiM, WangY, et al.Exosome/metformin-loaded self-healing conductive hydrogel rescues microvascular dysfunction and promotes chronic diabetic wound healing by inhibiting mitochondrial fission. Bioact Mater, 2023; 26:323–336; doi: 10.1016/j.bioactmat.2023.01.020
54.
KiyiciS, ErsoyC, KaderliA, et al.Effect of rosiglitazone, metformin and medical nutrition treatment on arterial stiffness, serum MMP-9 and MCP-1 levels in drug naive type 2 diabetic patients. Diabetes Res Clin Pract, 2009; 86(1):44–50; doi: 10.1016/j.diabres.2009.07.004
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
